Costica Aloman to End Stage Liver Disease
This is a "connection" page, showing publications Costica Aloman has written about End Stage Liver Disease.
Connection Strength
0.905
-
Recipient risk factors for acute cellular rejection after orthotopic liver transplant - a single-center, retrospective study. Transpl Int. 2020 12; 33(12):1779-1787.
Score: 0.729
-
The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients. Clin Transplant. 2016 Mar; 30(3):241-6.
Score: 0.131
-
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. Lancet Gastroenterol Hepatol. 2020 11; 5(11):1008-1016.
Score: 0.045